The drugmaker, which has been signaling for months that cutbacks would be made late this year, is now looking to eliminate jobs, including scientists at its research campuses in Groton and New London, Connecticut, next month as part of various organizational changes,The Day reports. Sales reps are also expected to be thrown overboard.
In a letter to employees, Rod MacKenzie, Pfizer's head of worldwide discovery research, wrote that, "given the complexity of the changes within research, I have concluded that we will not be able to provide that clarity or communicate them by the end of the year," the paper writes. "However, I remain committed to reshaping worldwide research, to getting these decisions right, and we will communicate the organizational changes, and what they mean to every Worldwide Research colleague, as soon as possible."
Last October, you may recall, Pfizer reorganized into three business units and made plans to drop research in several therapeutic areas. At the time, the drugmaker acknowledged layoffs would occur, but not immediately (back stories here, here and here).